A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery-Reference-Cited by-同舟云学术

A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery

Published:2003-04 Issue:3 Volume:29 Page:261-265
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Mohamed F,Marchettini P,Stuart O.A,Yoo D,Sugarbaker P.H

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference18 articles.

1. Theoretical and experimental bases of intraperitoneal chemotherapy;Dedrick;Semin Oncol,1985

2. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy;Elias;Cancer,2001

3. Taxol metabolism. Isolation and identification of three major metabolites in rat bile;Montsarrat;Drug Med Disp,1990

4. Montsarrat, B, Wright, M, Dubois, J, Taxol metabolism in rat and human bile, Proceedings of Seventh NCI-EORTC Symposium on new Drug Development, March 1992, Amsterdam

5. Intraperitoneal chemotherapy;Markman;Semin Oncol,1991

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies;Drugs;2023-01-12

2. Optimizing regional chemotherapy for epithelial ovarian cancer;Journal of Obstetrics and Gynaecology Research;2022-03-27

3. The many faces of intraperitoneal chemotherapy;Surgical Oncology;2022-03

4. Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects;Journal of Gastrointestinal Oncology;2021-04

5. Application of IPC, HIPEC, and PIPAC;Peritoneal Tumors and Metastases;2021